Literature DB >> 6488490

Release of endogenous catecholamines in the ischemic myocardium of the rat. Part B: Effect of sympathetic nerve stimulation.

A M Dart, A Schömig, R Dietz, E Mayer, W Kübler.   

Abstract

The contribution of centrally originating sympathetic activity to the myocardial extracellular accumulation of noradrenaline during the early phase of ischemia has been assessed in a perfused (Langendorff) rat heart preparation isolated except for its sympathetic innervation. A 10-minute electrical stimulation (4 Hz, 5 V) of the left cervicothoracic ganglion during normal perfusion causes the overflow of 177.5 +/- 13.7 pmol noradrenaline/g heart, whereas such stimulation during ischemia liberates only 21.5 +/- 3.6 pmol/g (collected during reperfusion). When neuronal reuptake is blocked by desipramine, corresponding values are 321.5 +/- 22.5 pmol/g (normal flow) and 151.8 +/- 22.4 pmol/g (ischemia). After combined blockade of neuronal uptake, extraneuronal uptake, and alpha 2-receptors, nerve stimulation liberates 674 +/- 22 pmol/g during normal flow and 206 +/- 24.3 pmol/g during ischemia. These results suggest that, in vivo, centrally originating neural activity would not lead to substantial accumulation of noradrenaline within the extracellular space of the ischemic myocardium. This failure of accumulation is due to both a functioning neuronal uptake of noradrenaline and a failure of neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488490     DOI: 10.1161/01.res.55.5.702

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  15 in total

1.  A microdialysis investigation of the release of norepinephrine in the hypothalamus induced by 2-deoxyglucose in awake rats.

Authors:  A I Kuz'min; M B Bogdanov; O S Medvedev
Journal:  Neurosci Behav Physiol       Date:  1992 Sep-Oct

Review 2.  Cardioprotection: definition, classification, and fundamental principles.

Authors:  W Kübler; M Haass
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

Review 3.  Evaluating presynaptic and postsynaptic innervation in heart failure.

Authors:  Grace P Chen; James H Caldwell
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

4.  Antiarrhythmic and antinecrotic effects of yohimbine stereoisomers in rats during coronary occlusion and reperfusion.

Authors:  W Bernauer
Journal:  Basic Res Cardiol       Date:  1990 Mar-Apr       Impact factor: 17.165

5.  Effects of long-term treatment with eicosapentaenoic acid on the heart subjected to ischemia/reperfusion and hypoxia/reoxygenation in rats.

Authors:  S Takeo; Y Nasa; K Tanonaka; K Yabe; M Nojiri; M Hayashi; H Sasaki; K Ida; K Yanai
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

6.  Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia.

Authors:  G Münch; T Kurz; T Urlbauer; M Seyfarth; G Richardt
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Potentiation of potassium-evoked noradrenaline and neuropeptide Y co-release by cardiac energy depletion: role of calcium channels and sodium-proton exchange.

Authors:  M Haass; G Richardt; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

8.  Metabolic requirements for release of endogenous noradrenaline during myocardial ischaemia and anoxia.

Authors:  A M Dart; R A Riemersma; A Schömig; A Ungar
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

9.  Effects of morphine on catecholamine release and arrhythmias evoked by myocardial ischaemia in rats.

Authors:  K Addicks; H Hirche; F M McDonald; W Polwin
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

10.  Reduced neuronal noradrenaline overflow in the ischaemic rat heart: importance of the severity of coronary flow reduction.

Authors:  X J Du; R A Riemersma
Journal:  Basic Res Cardiol       Date:  1991 Jan-Feb       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.